Drug
MF101
MF101 is a pharmaceutical drug with 4 clinical trials. Historical success rate of 66.7%.
Total Trials
4
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
66.7%
Based on 2 completed trials
Completion Rate
67%(2/3)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Terminated
1(25%)
Phase Distribution
Ph phase_1
2
50%
Ph phase_2
2
50%
Phase Distribution
2
Early Stage
2
Mid Stage
0
Late Stage
Phase Distribution4 total trials
Phase 1Safety & dosage
2(50.0%)
Phase 2Efficacy & side effects
2(50.0%)
Highest Phase Reached
Phase 2Trial Status & Enrollment
Completion Rate
66.7%
2 of 3 finished
Non-Completion Rate
33.3%
1 ended early
Currently Active
0
trials recruiting
Total Trials
4
all time
Status Distribution
Completed(2)
Terminated(1)
Other(1)
Detailed Status
Completed2
Terminated1
unknown1
Development Timeline
Analytics
Development Status
Total Trials
4
Active
0
Success Rate
66.7%
Most Advanced
Phase 2
Trials by Phase
Phase 12 (50.0%)
Phase 22 (50.0%)
Trials by Status
completed250%
terminated125%
unknown125%
Recent Activity
0 active trials
Showing 4 of 4
unknownphase_1
A Clinical Trial Assessing Safety of MF101 for Hot Flushes
NCT01300078
terminatedphase_1
Phase I Study to Evaluate the Safety and Efficacy of MF101 as Well as the Pharmacokinetics of Its Key Active Components
NCT00453297
completedphase_2
Clinical Trial Assessing Toxicity and Efficacy of MF101 for Hot Flashes
NCT00119665
completedphase_2
Sleep Quality in CHIMES (MF101)
NCT00454441
Clinical Trials (4)
Showing 4 of 4 trials
NCT01300078Phase 1
A Clinical Trial Assessing Safety of MF101 for Hot Flushes
NCT00453297Phase 1
Phase I Study to Evaluate the Safety and Efficacy of MF101 as Well as the Pharmacokinetics of Its Key Active Components
NCT00119665Phase 2
Clinical Trial Assessing Toxicity and Efficacy of MF101 for Hot Flashes
NCT00454441Phase 2
Sleep Quality in CHIMES (MF101)
All 4 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 4